Dallas, TX -- (ReleaseWire) -- 05/30/2014 -- The immunoassay instruments and reagents had witnessed a tremendous change and significant innovation since their evolution in the early nineties. The global market is valued at about $13.0 billion in 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $19.1 billion by 2018.
Browse 118 market data tables with 86 figures spread through 421 pages and in-depth TOC on "Immunoassay Market”.
Early buyers will receive 10% customization on this report.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=436
The expanding use of immunoassays, increasing demand for high quality healthcare services, and rapidly increasing geriatric population are the major factors that drives the global market. New and innovative product launches by key industry players also boosts the growth momentum of the market. Nevertheless, the rising commoditization of certain immunoassays, uncertain regulatory environment, and reduction in the healthcare budget are critical restraints for the market growth.
This research report categorizes the global market on the basis of technology, applications, products (analyzers and reagents), and end-users. On the basis of technology, the enzyme immunoassays segment accounted for the largest share of 35.2% of the global market in 2012.
By application, this market has segments like oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, hematology, neonatal screening, and others. Infectious disease is the largest segment with more than one-third share of the total market. This is attributed to the increasing prevalence of infectious diseases along with continuous product innovations and launches.
The key market vendors in this arena are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Danaher Corporation (U.S.), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).
Browse related reports:
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets